Table: OncoTherapy Science - 9-MTH group results

OncoTherapy Science

08/02/2019 08:00

Feb 8 (Reuters)- 
             OncoTherapy Science Inc 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2018        Dec 31, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            247 mln             203 mln                    
                 (+22.0 pct)         (-13.5 pct)                  
  Operating       loss 2.15           loss 2.22                   
  Recurring       loss 2.15           loss 2.22                   
  Net             loss 1.89           loss 2.15                   
  EPS          loss 12.89 yen      loss 14.60 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div
  -Q4 div                                NIL              NIL     
  
  NOTE - OncoTherapy Science Inc. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4564.T